Authors:
ISAAC L
AIVAZIAN D
TANIGUCHISIDLE A
EBANKS RO
FARAH CS
FLORIDO MPC
PANGBURN MK
ISENMAN DE
Citation: L. Isaac et al., NATIVE CONFORMATIONS OF HUMAN-COMPLEMENT COMPONENTS C3 AND C4 SHOW DIFFERENT DEPENDENCIES ON THIOESTER FORMATION, Biochemical journal, 329, 1998, pp. 705-712
Authors:
ISENMAN DE
NAGAR B
JONES RG
CLEMENZA L
DIEFENBACH RJ
RINI JM
Citation: De. Isenman et al., X-RAY CRYSTAL-STRUCTURE OF COMPLEMENT FRAGMENT C3D - THE LIGAND FOR CR-2, Molecular immunology, 35(6-7), 1998, pp. 113-113
Citation: Ae. Oran et De. Isenman, RESIDUES IN THE 727-767 SEGMENT OF C3 IMPORTANT FOR BINDING OF H AND CR-1 TO C3B, Molecular immunology, 35(6-7), 1998, pp. 114-114
Authors:
NAGAR B
JONES RG
DIEFENBACH RJ
ISENMAN DE
RINI JM
Citation: B. Nagar et al., X-RAY CRYSTAL-STRUCTURE OF C3D - A C3 FRAGMENT AND LIGAND FOR COMPLEMENT RECEPTOR-2, Science, 280(5367), 1998, pp. 1277-1281
Authors:
CHEN FH
ARYA SK
RINFRET A
ISENMAN DE
SHULMAN MJ
PAINTER RH
Citation: Fh. Chen et al., DOMAIN-SWITCHED MOUSE IGM IG2B HYBRIDS INDICATE INDIVIDUAL ROLES FOR C-MU-2, C-MU-3, AND C-MU-4 DOMAINS IN THE REGULATION OF THE INTERACTION OF IGM WITH COMPLEMENT C1Q/, The Journal of immunology, 159(7), 1997, pp. 3354-3363
Citation: Ro. Ebanks et De. Isenman, MOUSE COMPLEMENT COMPONENT C4 IS DEVOID OF CLASSICAL PATHWAY C5 CONVERTASE SUBUNIT ACTIVITY, Molecular immunology, 33(3), 1996, pp. 297-309
Citation: Mj. Wong et al., PROCESSING OF HUMAN FACTOR-I IN COS-1 CELLS CO-TRANSFECTED WITH FACTOR-I AND PAIRED BASIC-AMINO-ACID CLEAVING ENZYME (PACE) CDNA, Molecular immunology, 32(5), 1995, pp. 379-387
Citation: Ro. Ebanks et De. Isenman, EVIDENCE FOR THE INVOLVEMENT OF ARGININE-462 AND THE FLANKING SEQUENCE OF HUMAN C4 BETA-CHAIN IN MEDIATING C5 BINDING TO THE C4B SUBCOMPONENT OF THE CLASSICAL COMPLEMENT PATHWAY C5 CONVERTASE, The Journal of immunology, 154(6), 1995, pp. 2808-2820
Citation: Rj. Diefenbach et De. Isenman, MUTATION OF RESIDUES IN THE C3DG REGION OF HUMAN-COMPLEMENT COMPONENTC3 CORRESPONDING TO A PROPOSED BINDING-SITE FOR COMPLEMENT RECEPTOR-TYPE-2 (CR-2, CD21) DOES NOT ABOLISH BINDING OF IC3B OR C3DG TO CR-2, The Journal of immunology, 154(5), 1995, pp. 2303-2320
Citation: Rj. Diefenbach et De. Isenman, MUTAGENESIS OF RESIDUES IN THE REGION OF HUMAN-COMPLEMENT COMPONENT C3 THAT CORRESPONDS TO THE PROPOSED BINDING-SITE FOR COMPLEMENT RECEPTOR 2 (CR-2, CD21) DOES NOT ABOLISH BINDING OF IC3B OR C3DG TO CR-2, The FASEB journal, 8(5), 1994, pp. 10000766-10000766
Authors:
CHEN FH
ISENMAN DE
SHULMAN MJ
ARYA SK
PAINTER RH
Citation: Fh. Chen et al., STUDIES ON THE INTERACTION BETWEEN IGM AND C1Q USING DOMAIN-SHUFFLED HYBRID IGM-IGG ANTIBODIES, The FASEB journal, 8(5), 1994, pp. 10000767-10000767
Citation: A. Taniguchisidle et De. Isenman, INTERACTIONS OF HUMAN-COMPLEMENT COMPONENT C3 WITH FACTOR AND AND WITH COMPLEMENT RECEPTORS TYPE-1 (CR-1, CD35) AND TYPE-3 (CR3, CD11B CD18) INVOLVE AN ACIDIC SEQUENCE AT THE N-TERMINUS OF C3 ALPHA'-CHAIN/, The Journal of immunology, 153(11), 1994, pp. 5285-5302
Authors:
TAYLOR B
WRIGHT JF
ARYA S
ISENMAN DE
SHULMAN MJ
PAINTER RH
Citation: B. Taylor et al., C1Q BINDING-PROPERTIES OF MONOMER AND POLYMER FORMS OF MOUSE IGM MU-CHAIN VARIANTS - PRO544GLY AND PRO434ALA, The Journal of immunology, 153(11), 1994, pp. 5303-5313
Authors:
ARYA S
CHEN F
SPYCHER S
ISENMAN DE
SHULMAN MJ
PAINTER RH
Citation: S. Arya et al., MAPPING OF AMINO-ACID-RESIDUES IN THE C-MU-3 DOMAIN OF MOUSE IGM IMPORTANT IN MACROMOLECULAR ASSEMBLY AND COMPLEMENT-DEPENDENT CYTOLYSIS, The Journal of immunology, 152(3), 1994, pp. 1206-1212
Citation: S. Chappel et al., IDENTIFICATION OF AN ACCESSORY FCRI BINDING-SITE WITHIN A GENETICALLYENGINEERED HUMAN-IGG ANTIBODY, The Journal of immunology, 150(8), 1993, pp. 8-8
Citation: Ro. Ebanks et De. Isenman, ANALYSIS BY SITE-DIRECTED MUTAGENESIS OF A POTENTIAL BINDING-SITE IN HUMAN C4 FOR C5, The Journal of immunology, 150(8), 1993, pp. 13-13
Authors:
CHAPPEL MS
ISENMAN DE
OOMEN R
XU YY
KLEIN MH
Citation: Ms. Chappel et al., IDENTIFICATION OF A SECONDARY FC-GAMMA-RI BINDING-SITE WITHIN A GENETICALLY-ENGINEERED HUMAN-IGG ANTIBODY, The Journal of biological chemistry, 268(33), 1993, pp. 25124-25131